Technology-Enhanced Asthma Care in Children at Clinic and Home Study

Inclusion Criteria

• •Inclusion into the study will not depend on sex, ethnicity, or race. We will monitor enrollment to ensure a diversity of sex and race/ethnicity are represented.
• •1. Caregivers must be at least 18 years old (defined as parent or legal guardian)
• •2. The child (patient) has a diagnosis of asthma associated with a clinic visit in the electronic health record
• •3. The child is between the ages of 4-17 years old at the time of recruitment
• •1. The study is interested in the self-management of asthma by caregivers, whom are still primarily responsible for their child's chronic disease management.
• •2. Children younger than 4 years old will not be included in this study as the diagnosis of asthma is typically difficult to confirm in younger ages.
• •4. The child is prescribed inhaled corticosteroid or corticosteroid/long-acting beta agonist combination for daily use. The patient can have an inhaled corticosteroid/long-acting beta agonist for both daily preventive and rescue use, as in Single Maintenance and Reliever Therapy (SMART).
• •5. Persistent or un controlled asthma based on NHLBI guidelines40; Any 1 of the following:
• •1. In past month, \>2 days per week with asthma symptoms
• •2. \>2 days per week with rescue medication use
• •3. \>2 days per month with nighttime awakenings (for children who are not taking a controller asthma medication) OR \>2 days per month with nighttime awakenings (for children who are currently taking a controller asthma medication)
• •4. \>2 asthma episodes during the past year that required systemic corticosteroids
• •6. The child is a patient in Primary Care Uptown, Primary Care Deming, Allergy, or Pulmonary Clinics at LCH
• •1. Participant is an employee of LCH system
• •2. Works at or supports the operations of Primary Care Uptown, Primary Care Deming, Allergy, or Pulmonary Clinics at LCH
• •3. Able to provide informed consent